Search results
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 1 hour agoThe funding is earmarked to support the Phase 1 TRAVERSE trial, which is evaluating the safety and...
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 3 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 19 hours agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
New study provides genomic insights into kidney cancer risk
National Cancer Institute· 8 hours agoIn a new analysis of genetic susceptibility to kidney cancer, an international team of researchers...
Moriah Elyse Kerns - Valencia County News-Bulletin
Valencia County News-Bulletin· 1 day agoMoriah Elyse Kerns, age 27, a resident of Los Lunas, passed away on April 20, 2024, as a result of renal cell carcinoma. Moriah was pursuing ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoPatients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 22 hours agoKeytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 21 hours agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
NBC 10 - FOX 14 Monroe· 2 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class PD-1/IL-2 bispecific ...
Cancer drug trial provides lessons for future
Medical Xpress· 22 hours agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal ...